Skip to main content

Table 4 Parameter estimates predicting the mean monthly EQ-5D-3L level among surgically treated patients

From: A pain relieving reimbursement program? Effects of a value-based reimbursement program on patient reported outcome measures

Parameter EQ-5D-3L baseline EQ-5D-3L 1-year follow up EQ-5D-3L Δ (follow up-baseline)
Estimate SE p-value Estimate SE p-value Estimate SE p-value
Intercept 0.365 0.01 <.0001 0.686 0.011 <.0001 0.319 0.016 <.0001
Time 0.0001 0 0.488 −0.0001 0.0002 0.532 0.0004 0.0003 0.143
VBRP −0.015 0.021 0.483 −0.004 0.022 0.85 0.001 0.033 0.972
Time after −0.0001 0.001 0.956 0.0001 0.001 0.938 0.001 0.002 0.751
July −0.113 0.018 <.0001 0.117 0.018 <.0001 0.279 0.027 <.0001
  1. Note: SE Standard error, Intercept, the EQ-5D-3L level in January 2006; Time, number of months from January 2006; VBRP, indicates the introduction of the STHLM-VBRP in the end of 2013; which is 92 months after January 2006 (Time = 92); Time after, number of months after the introduction of VBRP (hence Time-91); July, indicates the month of July
  2. Parameter estimates from the segmented regression analysis predicting the mean monthly EQ-5D-3L level among surgically treated patients before and after the introduction of the STHLM-VBRP, 2006–2015. The introduction of the reimbursement program had no effect on level (VBRP) nor trend (Time after) of EQ-5D-3L